Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 06:51:38 +0200Fri, 24 May 2024 15:08:00 +0200Human medicines European public assessment report (EPAR): Sprycel, dasatinib (anhydrous), Date of authorisation: 20/11/2006, Revision: 43, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/sprycelHuman medicines European public assessment report (EPAR): Sprycel, dasatinib (anhydrous), Date of authorisation: 20/11/2006, Revision: 43, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/sprycelFri, 24 May 2024 15:08:00 +0200Human medicineSprycel : EPAR - Procedural steps taken and scientific information after authorisationhttps://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-0709-steps-after_en.pdfSprycel : EPAR - Procedural steps taken and scientific information after authorisationhttps://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-0709-steps-after_en.pdfFri, 24 May 2024 14:07:00 +0200Human medicine